Combined Therapy against Recurrent Hemangiopericytoma: A Case Report

Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China A patient with a seven-year history of recurrent metastatic hemangiopericytoma (HPC) was admitted. During his treatment, he received surgical resection, radiotherapy, radiofrequency hyperthermia and...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiao-dong, Jiang, Jing-ting, Wu, Chang-ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643657/
https://www.ncbi.nlm.nih.gov/pubmed/23691471
http://dx.doi.org/10.3969/j.issn.2095-3941.2012.02.012
_version_ 1782268350497292288
author Li, Xiao-dong
Jiang, Jing-ting
Wu, Chang-ping
author_facet Li, Xiao-dong
Jiang, Jing-ting
Wu, Chang-ping
author_sort Li, Xiao-dong
collection PubMed
description Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China A patient with a seven-year history of recurrent metastatic hemangiopericytoma (HPC) was admitted. During his treatment, he received surgical resection, radiotherapy, radiofrequency hyperthermia and chemotherapy using combined doxorubicin, dacarbazin, vincristine, ginsenoside Rg3, and recombinant human endostatin. This synergistic method provides an encouraging model for treating HPC.
format Online
Article
Text
id pubmed-3643657
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Chinese Anti-Cancer Association
record_format MEDLINE/PubMed
spelling pubmed-36436572013-05-20 Combined Therapy against Recurrent Hemangiopericytoma: A Case Report Li, Xiao-dong Jiang, Jing-ting Wu, Chang-ping Cancer Biol Med Case Report Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China A patient with a seven-year history of recurrent metastatic hemangiopericytoma (HPC) was admitted. During his treatment, he received surgical resection, radiotherapy, radiofrequency hyperthermia and chemotherapy using combined doxorubicin, dacarbazin, vincristine, ginsenoside Rg3, and recombinant human endostatin. This synergistic method provides an encouraging model for treating HPC. Chinese Anti-Cancer Association 2012-06 /pmc/articles/PMC3643657/ /pubmed/23691471 http://dx.doi.org/10.3969/j.issn.2095-3941.2012.02.012 Text en 2012 Cancer Biology & Medicine This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/
spellingShingle Case Report
Li, Xiao-dong
Jiang, Jing-ting
Wu, Chang-ping
Combined Therapy against Recurrent Hemangiopericytoma: A Case Report
title Combined Therapy against Recurrent Hemangiopericytoma: A Case Report
title_full Combined Therapy against Recurrent Hemangiopericytoma: A Case Report
title_fullStr Combined Therapy against Recurrent Hemangiopericytoma: A Case Report
title_full_unstemmed Combined Therapy against Recurrent Hemangiopericytoma: A Case Report
title_short Combined Therapy against Recurrent Hemangiopericytoma: A Case Report
title_sort combined therapy against recurrent hemangiopericytoma: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643657/
https://www.ncbi.nlm.nih.gov/pubmed/23691471
http://dx.doi.org/10.3969/j.issn.2095-3941.2012.02.012
work_keys_str_mv AT lixiaodong combinedtherapyagainstrecurrenthemangiopericytomaacasereport
AT jiangjingting combinedtherapyagainstrecurrenthemangiopericytomaacasereport
AT wuchangping combinedtherapyagainstrecurrenthemangiopericytomaacasereport

Ejemplares similares